Tag Archives: Depression

FDA Approves Spravato (esketamine) Nasal Spray for Treatment-Resistant Depression

Print this page March 5, 2019 — The U.S. Food and Drug Administration today approved Spravato (esketamine) nasal spray, in conjunction with an oral antidepressant, for the treatment of depression in adults who have tried other antidepressant medicines but have not benefited from them (treatment-resistant depression). Because of the risk of serious adverse outcomes resulting… Read More »

Perinatal Depression: How Do We Define High Risk? (Part 1)

In 2016, the US Preventive Services Task Force (USPSTF) recommended that all adults, including pregnant and postpartum women, should be screened for depression; the task force has extended those recommendations by stating that all pregnant and postpartum women should be evaluated in order to determine risk for depressive illness and suggests that women at increased… Read More »

Preventing postpartum depression: Start with women at greatest risk

January 30, 2019 from ObGynNews The last decade has brought appropriate attention to the high prevalence of postpartum mood and anxiety disorders, with postpartum depression (PPD) constituting the most common complication in modern obstetrics. There have been very substantial efforts in more than 40 states in the United States to enhance screening for PPD and… Read More »